Aakash Desai: Proteomic Characterization of ADC Target Expression Profiles in SCLC

Aakash Desai, Assistant Professor at UAB O’Neal Comprehensive Cancer Center, shared a post on LinkedIn:

“Excited to share that our team presented research on proteomic characterization of antibody-drug conjugate (ADC) target expression profiles in small cell lung cancer (SCLC) at WCLC24!

Proteomic Characterization of ADC Target Expression Profiles in SCLC
Key takeaways:
• Analysis of 214 samples reveals significant findings on target expressions for ADCs
• These findings provide insights for optimizing therapeutic approaches in SCLC and optimizing patient selection!
We need to continue to push the envelope in personalized oncology for SCLC!”

He also shared:

“Thrilled to have Atulya Aman Khosla present our latest research on protein-based target identification for optimizing bispecific antibody use in non-small cell lung cancer (NSCLC) at WCLC24!  International Association for the Study of Lung Cancer

Optimizing Bispecific Antibody Use in NSCLC

Key insights:

• Unique proteomic signatures for LUAD identified
• 5 distinct BsAbs target expression profiles identified
• These insights will help in enhancing drug design for better therapeutic outcomes”

Source: Aakash Desai/LinkedIn